Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal

Clinical Microbiology and Infection

Volumn 14, Issue 12, 2008, Pages 1152-1159

  Silva Costa, C ^a   Pinto, F R ^a   Ramirez, M ^a   Melo Cristino, J ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Clonal types; Macrolide resistance; Portugal; Resistance prevalence; Sequence types; Streptococcus pyogenes

Indexed keywords

BACTERIAL PROTEIN; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; PROTEIN ERM A; PROTEIN ERM B; PROTEIN MEF A; PROTEIN MEF E; PROTEIN TET M; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CLONAL VARIATION; MICROBIAL DIVERSITY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPIC VARIATION; PORTUGAL; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPING; STREPTOCOCCUS PYOGENES;

STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 57749088762     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02104.x     Document Type: Article

References (32)

1. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002; 34: 482-492.
2. Roberts MC, Sutcliffe J, Courvalin P et al. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999; 43: 2823-2830.
3. Brenciani A, Bacciaglia A, Vecchi M et al. Genetic elements carrying erm (B) in Streptococcus pyogenes and association with tet (M) tetracycline resistance gene. Antimicrob Agents Chemother 2007; 51: 1209-1216.
4. Sangvik M, Littauer P, Simonsen GS, Sundsfjord A, Dahl KH. mef (A), mef (E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway. J Antimicrob Chemother 2005; 56: 841-846.
5. Ardanuy C, Tubau F, Linares J et al. Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes. Antimicrob Agents Chemother 2005; 49: 827-829.
6. Figueiredo TA, Aguiar SI, Melo-Cristino J, Ramirez M. DNA methylase activity as a marker for the presence of a family of phage-like elements conferring efflux-mediated macrolide resistance in streptococci. Antimicrob Agents Chemother 2006; 50: 3689-3694.
7. Bingen E, Leclercq R, Fitoussi F et al. Emergence of group A streptococcus strains with different mechanisms of macrolide resistance. Antimicrob Agents Chemother 2002; 46: 1199-1203.
8. Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 2004; 10: 514-517.
9. Bergman M, Huikko S, Pihlajamaki M et al. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis 2004; 38: 1251-1256.
10. Granizo JJ, Aguilar L, Casal J, Dal-Re R, Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother 2000; 46: 959-964.
11. Coenen S, Ferech M, Malhotra-Kumar S et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 2006; 58: 418-422.
12. SeppäläH, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441-446.
13. Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: A randomised, double-blind, placebo-controlled study. Lancet 2007; 369: 482-490.
14. Maynard-Smith J, Smith NH, O'Rourke M, Spratt BG. How clonal are bacteria? Proc Natl Acad Sci USA 1993; 90: 4384-4388.
15. Friães A, Ramirez M, Melo-Cristino J. Nonoutbreak surveillance of group A streptococci causing invasive disease in Portugal identified internationally disseminated clones among members of a genetically heterogeneous population. J Clin Microbiol 2007; 45: 2044-2047.
16. Silva-Costa C, Ramirez M, Melo-Cristino J. Identification of macrolide-resistant clones of Streptococcus pyogenes in Portugal. Clin Microbiol Infect 2006; 12: 513-518.
17. Levin BR, Bergstrom CT. Bacteria are different: Observations, interpretations, speculations, and opinions about the mechanisms of adaptive evolution in prokaryotes. Proc Natl Acad Sci USA 2000; 97: 6981-6985.
18. Silva-Costa C, Ramirez M, Melo-Cristino J. Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal. Antimicrob Agents Chemother 2005; 49: 2109-2111.
19. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, sixteenth informational supplement. CLSI document M100-S16. Wayne, PA: CLSI, 2006.
20. Melo-Cristino J, Fernandes ML. The Portuguese Surveillance Group for the Study of Respiratory Pathogens. Streptococcus pyogenes isolated in Portugal: Macrolide resistance phenotypes and correlation with T types. Microb Drug Resist 1999; 5: 219-225.
21. Figueira-Coelho J, Ramirez M, Salgado MJ, Melo-Cristino J. Streptococcus agalactiae in a large Portuguese teaching hospital: Antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Microb Drug Resist 2004; 10: 31-36.
22. Trzcinski K, Cooper BS, Hryniewicz W, Dowson CG. Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2000; 45: 763-770.
23. Beall B, Facklam RR, Elliott JA et al. Streptococcal emm types associated with T-agglutination types and the use of conserved emm gene restriction fragment patterns for subtyping group A streptococci. J Med Microbiol 1998; 47: 893-898.
24. Carriço JA, Silva-Costa C, Melo-Cristino J et al. Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes. J Clin Microbiol 2006; 44: 2524-2532.
25. Enright MC, Spratt BG, Kalia A, Cross JH, Bessen DE. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun 2001; 69: 2416-2427.
26. Altman DG. Practical statistics for medical research. Boca Raton, FL: Chapman & Hall/CRC, 1999.
27. Altman DG, Machin D, Bryant TN, Gardner MJ. Statistics with confidence, 2nd edn. Bristol: BMJ Books, 2000.
28. Eriksson BK, Norgren M, McGregor K, Spratt BG, Normark BH. Group A streptococcal infections in Sweden: A comparative study of invasive and noninvasive infections and analysis of dominant T28 emm 28 isolates. Clin Infect Dis 2003; 37: 1189-1193.
29. Pérez-Trallero E, Vicente D, Montes M, Marimon JM, Piñeiro L. High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults. J Antimicrob Chemother 2001; 48: 225-229.
30. Pérez-Trallero E, Montes M, Orden B et al. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLS B phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob Agents Chemother 2007; 51: 1228-1233.
31. Grivea IN, Al-Lahham A, Katopodis GD, Syrogiannopoulos GA, Reinert RR. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: Phenotypic and genotypic analysis. Antimicrob Agents Chemother 2006; 50: 256-261.
32. Reinert RR, Haupts S, van der Linden M et al. Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003. Clin Microbiol Infect 2005; 11: 985-991.